Rheumatic Disease
20
2
3
9
Key Insights
Highlights
Success Rate
90% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
5.0%
1 terminated out of 20 trials
90.0%
+3.5% vs benchmark
15%
3 trials in Phase 3/4
22%
2 of 9 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 9 completed trials
Clinical Trials (20)
Natural History, Pathogenesis and Outcome of Melorheostosis A Rare Osteosclerotic Disease
Immunosuppressant Management in Rheumatology Patients Undergoing Elective Total Shoulder Arthroplasty
Autoimmune and Autoinflammatory Genetics Study
Gemelli Longitudinal Cohort on Long-term Outcomes in RheumatIc diseAses
COVID-19 CoronaVac in Patients With Autoimmune Rheumatic Diseases and HIV/AIDS
Patient Engagement With Digital Health Tools in Rheumatology
Survey About Diet in Chronic Inflammatory Rheumatic Diseases
Aerobic Exercise in Women With Systemic Lupus Erythematosus
Strategies to Improve Appropriate Referral to Rheumatologists
Telerehabilitation in Women With Rheumatic Disease
Safety and Immunogenicity of Sars-cov-2 Vaccine in Patients With Rheumatic Diseases
Latest Imaging SPECT System Evaluation Phase 1
Comparing Modes of Telehealth Delivery: Phone vs. Video Visits (ASSIST)
Patient Experiences in Rheumatology
Protocol For The Quantitation Of Pain In The Diagnosis Of Polymyalgia Rheumatica
Acetaminophen (Tylenol) for Mood and Memory Changes Associated With Corticosteroid Therapy
Heated Pool Exercise Groups for Patients With Rheumatic Diseases
The Usefulness of Interferon-γ Release Assays and Tuberculin Skin Test for Detection of Latent Tuberculosis Infection
Vaccine Responses to Influenza A H1N1/09 Immunization in High-risk Patients
Intraarticular Opioids Vs Glucocorticosteroids in Gonarthritis